Cyclacel Pharma (CYCC) Reports Q3 Loss of $0.11/Share
Tweet
Share
E-mailGet Alerts CYCC Hot Sheet
Price: $6.37 --0%
Financial Fact:
Foreign exchange (losses)/gains: 51K
Today's EPS Names:
DTGI, CRMT, MAYS, More
Financial Fact:
Foreign exchange (losses)/gains: 51K
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Cyclacel Pharma (NASDAQ: CYCC) reported Q3 EPS of ($0.11), versus ($0.18) reported last year.
For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk and Micron surge as Apple confirms memory price pass-through
- SpaceX receives Baa1 rating from Moody's with stable outlook
- Goldman starts Talen at buy, sees PJM power tightness boosting earnings
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
